, Volume 36, Issue 1, pp 62–67 | Cite as

Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth

  • D. J. P. Barker
  • C. N. Hales
  • C. H. D. Fall
  • C. Osmond
  • K. Phipps
  • P. M. S. Clark


Two follow-up studies were carried out to determine whether lower birthweight is related to the occurrence of syndrome X — Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia. The first study included 407 men born in Hertfordshire, England between 1920 and 1930 whose weights at birth and at 1 year of age had been recorded by health visitors. The second study included 266 men and women born in Preston, UK, between 1935 and 1943 whose size at birth had been measured in detail. The prevalence of syndrome X fell progressively in both men and women, from those who had the lowest to those who had the highest birthweights. Of 64-year-old men whose birthweights were 2.95 kg (6.5 pounds) or less, 22% had syndrome X. Their risk of developing syndrome X was more than 10 times greater than that of men whose birthweights were more than 4.31 kg (9.5 pounds). The association between syndrome X and low birthweight was independent of duration of gestation and of possible confounding variables including cigarette smoking, alcohol consumption and social class currently or at birth. In addition to low birthweight, subjects with syndrome X had small head circumference and low ponderal index at birth, and low weight and below-average dental eruption at 1 year of age. It is concluded that Type 2 diabetes and hypertension have a common origin in sub-optimal development in utero, and that syndrome X should perhaps be re-named “the small-baby syndrome”.

Key words

Type 2 (non-insulin-dependent) diabetes mellitus hypertension hyperlipidaemia syndrome X reduced fetal growth 


  1. 1.
    Hales CN, Barker DJP, Clark PMS et al. (1991) Fetal and infant growth and impaired glucose tolerance at age 64 years. BMJ 303: 1019–1022PubMedGoogle Scholar
  2. 2.
    Robinson S, Walton RJ, Clark PM, Barker DJP, Hales CN, Osmond C (1992) The relation of fetal growth to plasma glucose in young men. Diabetologia 35: 444–446PubMedGoogle Scholar
  3. 3.
    Barker DJP, Osmond C, Golding J, Kuh D, Wadsworth MEJ (1989) Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298: 564–567PubMedGoogle Scholar
  4. 4.
    Barker DJP, Bull AR, Osmond C, Simmonds SJ (1990) Fetal and placental size and risk of hypertension in adult life. BMJ 301: 259–262PubMedGoogle Scholar
  5. 5.
    Barker DJP, Meade TW, Fall CHD et al. (1992) Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ 304: 148–152PubMedGoogle Scholar
  6. 6.
    Stamler J, Rhomberg P, Schroenberger JA et al. (1975) Multivariate analysis of the relationship of seven variables to blood pressure: findings of the Chicago Heart Association detection project in industry. 1967–72. J Chron Dis 28: 527–548CrossRefPubMedGoogle Scholar
  7. 7.
    Modan M, Halkin H, Almog S et al. (1985) Hyperinsulinaemia: a link between hypertension obesity and glucose intolerance. J Clin Invest 75: 809–817PubMedGoogle Scholar
  8. 8.
    Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607PubMedGoogle Scholar
  9. 9.
    Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416–422PubMedGoogle Scholar
  10. 10.
    Yudkin J (1991) Hypertension and non-insulin dependent diabetes. BMJ 303: 730–731PubMedGoogle Scholar
  11. 11.
    Fontbonne A, Charles MA, Thibult N et al. (1991) Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year followup. Diabetologia 34: 356–361PubMedGoogle Scholar
  12. 12.
    Foster DW (1989) Insulin resistance, a secret killer? N Engl J Med 320: 733–734PubMedGoogle Scholar
  13. 13.
    Hales CN, Barker DJP (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35: 595–601PubMedGoogle Scholar
  14. 14.
    Barker DJP, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO (1991) The relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 303: 671–675PubMedGoogle Scholar
  15. 15.
    Kunst A, Draeger B, Ziegenhorn J (1983) UV-methods with hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, Vol VI. Weinheim Verlag Chemie, Deerfield, pp 163–172Google Scholar
  16. 16.
    Sobey WJ, Beer SF, Carrington CA, Gray IP et al. (1989) Sensitive and specific two-site immuno-radiometric assays for human insulin, proinsulin, 65–66 split and 32–33 split proinsulins. Biochem J 260: 535–541PubMedGoogle Scholar
  17. 17.
    Alpha B, Cox L, Crowther N, Clark PMS, Hales CN (1992) Sensitive amplified immunoenzymometric assays (IEMA) for human insulin and intact proinsulin. Eur J Clin Chem Biochem 30: 27–32Google Scholar
  18. 18.
    Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC (1974) Enzymatic determination of serum total cholesterol. Clin Chem 20: 470–475PubMedGoogle Scholar
  19. 19.
    Lie AF, Schmitz JM, Pierre KJ, Gochman N (1976) Cholesterol oxidase-based determination by continuous flow analysis of total and free cholesterol in serum. Clin Chem 22: 1627–1630PubMedGoogle Scholar
  20. 20.
    Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 23: 882–884PubMedGoogle Scholar
  21. 21.
    Fossati P, Prencipe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28: 2077–2080PubMedGoogle Scholar
  22. 22.
    Friedwald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18: 499–502PubMedGoogle Scholar
  23. 23.
    Bhatnagar D, Durrington PN (1991) Clinical value of apolipoprotein measurement. Ann Clin Biochem 28: 427–437PubMedGoogle Scholar
  24. 24.
    Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol (Basel) 17: 237–246Google Scholar
  25. 25.
    Brozovic M, Stirling Y, Harricks C, North WRS, Meade TW (1974) Factor VII in an industrial population. Br J Haematol 28: 381–391PubMedGoogle Scholar
  26. 26.
    Sundell IB, Nilsson TK, Hallmans G, Hellsten G, Dahlen GH (1989) Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a North Swedish population. Atherosclerosis 80: 9–16PubMedGoogle Scholar
  27. 27.
    Barker DJP (ed) (1992) Fetal and infant origins of adult disease, 1st edn. British Medical Journal, LondonGoogle Scholar
  28. 28.
    Barker DJP, Godfrey KM, Osmond C, Bull A (1992) The relation of fetal length, ponderal index and head circumference to blood pressure and the risk of hypertension in adult life. PaediatrPerinat Epidemiol 6: 35–44PubMedGoogle Scholar
  29. 29.
    Jarrett RJ (1992) In defence of insulin; a critique of syndrome X. Lancet 340: 469–471CrossRefPubMedGoogle Scholar
  30. 30.
    Lucas A (1991) Programming by early nutrition in man. In: Bock GR, Whelan J (eds) The childhood environment and adult disease. Ciba Foundation Symposium 156. John Wiley, Chichester pp 38–55Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • D. J. P. Barker
    • 1
  • C. N. Hales
    • 2
  • C. H. D. Fall
    • 1
  • C. Osmond
    • 1
  • K. Phipps
    • 1
  • P. M. S. Clark
    • 2
  1. 1.MRC Environmental Epidemiology UnitUniversity of Southampton, Southampton General HospitalSouthampton
  2. 2.Department of Clinical BiochemistryUniversity of Cambridge, Addenbrooke's HospitalCambridgeUK

Personalised recommendations